Reply to: low response of granulomatous cheilitis to currently established treatments.

Ali, N S; Sahni, V N; Ma, B C; Sahni, D R; Hull, C M; Powell, D L; Secrest, A M

Ali, N S; Sahni, V N; Ma, B C; Sahni, D R; Hull, C M; Powell, D L; Secrest, A M.

Afiliación

Ali NS; School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Sahni VN; College of Medicine, Drexel University, Philadelphia, PA, USA.
Ma BC; School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Sahni DR; Department of Dermatology, University of Utah Health, Salt Lake City, UT, USA.
Hull CM; Department of Dermatology, University of Utah Health, Salt Lake City, UT, USA.
Powell DL; Department of Dermatology, University of Utah Health, Salt Lake City, UT, USA.
Secrest AM; Department of Dermatology, University of Utah Health, Salt Lake City, UT, USA.

J Eur Acad Dermatol Venereol ; 35(12): e930-e931, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34370336

Asunto(s)

Queilitis; Enfermedad de Crohn; Síndrome de Melkersson-Rosenthal; Queilitis/tratamiento farmacológico; Humanos; Síndrome de Melkersson-Rosenthal/diagnóstico; Síndrome de Melkersson-Rosenthal/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Queilitis / Síndrome de Melkersson-Rosenthal Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google